Julio-Septiembre 2002 12
ISSN 1317-987X
 
Buscar




Artículos
 



Anatomía Patológica
Miocardiopatía hipertensiva versus miocardiopatía hipertrófica: Conceptos y aspectos morfológicos

Bibliografía

  1. World Health Organization - International Society of Hypertension. Guidelines for the management of hypertension. J Hyp 1999; 17:151-83.
  2. Fuster V. Epidemic of cardiovascular disease and stroke: The three main challenges. Circulation. 1999; 99:1132-37.
  3. Anderson BA, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalizaded population. Am Heart J 1993; 126:632-40.
  4. Kannel WB. Risk statification in hipertensión: New insights from the Framingham study. Am J Hypertens 2000; 13:35-105.
  5. Fragachán F. El problema de la hipertensión en Venezuela. Hip Exp Clin 1992; 1(1):2-8.
  6. Julins S, Mejía A, Jonesk. "White coat" versus "sustained" borderline hypertension in Tecumseh. Michigan. Hajp 1990; 16:617-23.
  7. Fragachán F. El problema de la hipertensión arterial en Venezuela. En: Manual de Normas y Procedimientos para el estudio del paciente con presión arterial elevada: hipertenso. Fragachán F, Chuki RE, Sanabria A. (eds) Tipografía Olimpia. Caracas 2001 p 835.
  8. Suárez C, Velasquez G, Avilan J, García ML. Enfermedades del miocardio: estudio post-mortem en 1891 autopsias. Gac Med Caracas 2001; 109:497-507.
  9. Gosse P, Dallocchio M. Left ventricular hypertrophy: epidemiological prognosis and associated critical factors. Eur Heart J 1993; 14 suppl D(8):16-21.
  10. Richardson P, Mc Kenna WJ, Briston M, Maisch B, Mantrer B, O´Connell Y, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93:841-42.
  11. Wagner BM. Probing the enigma of human idiopathic cardiomyopathy. Hum Pathol 2000; 31:893-94.
  12. Puigbó JJ, Combellas I, Giordano H, Acquatella H, Casol H, Tortolero F, Suárez C. Estudio sobre la miocardiopatía hipertrófica; aspectos clínicos, ecocardiográficos, hemodinámicos y angiocardiográficos en una serie de treinta pacientes. Gac Med Caracas 2001; 109:488-96.
  13. Puigbó JJ, Suárez C, Giordano H. Correlaciones anatomoclínicas en la enfermedad de chagas. Rev Fac Med 2000; 23 (suppl):547-53).
  14. Suárez C, Alvarez AR, Salazar CZ, Suárez L. Cardiomiopatía hipertrófica infantil y juvenil: estudio post-mortem. Bol Hosp. Uni Caracas 1993; 23:107-19.
  15. Shapiro L. Hypertrophic cardiomyopathy in the elderly. Br Heart J 1990; 63:265-76.
  16. Ghali JK, Lias J, Cooper RS. Left ventricular hypertrophy in the elderly. Am J Geriatr Cardiol 1997; 6:38-49.
  17. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J 1985; 312:277-80.
  18. Susic D, Frohlich ED. Hypertension and the heart. Curr Hypertens Rep 2000; 2:565-9.
  19. Pons Llado G, Ballester M, Borras X, Carreras F, Carrio I, López CJ, Rocca CA. Myocardial cell damage in human hypertension. J Am Coll Cardiol 2000; 36:2158-203.
  20. Stilli D, Berni R, Sgoifo A, Costoli T, Bocchi L, Cacciani F, Manghi M, Olivetti G, Musso E. Social stress, myocardial damage and arrythmias in rats with cardiac hypertrophy. Physiol Behav 2000; 73:351-8.
  21. Crisan D, Carr J. Angiotensin- converting enzyme. Genotype and disease associations. J Mol Diag 2000; 2:105-15.
  22. Weber KT, Anversa P, Armstrong P, Brilla C, Burnett J, Cruickshank J. Remodeling and reparation of cardiovascular system. JACC 1992;20:3-16.
  23. Vinereanu D, Floresan N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assement of a long-axis function in patients with hypertrophyc cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001; 88:53-8.
  24. Weber KT, Brilla C, Janicki J. Myocardial remodeling and pathologic hypertrophy. Hospital practice 1991; 15:73-80.
  25. Sackher- Bernstein JD. The myocardial matrix and the development and progression of ventricular remodeling. Curr Cardiol Rep 2000; 2:112-19.
  26. Cohn JN, Ferraru R, Sharpe N. Cardiac remodeling concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000; 35:569-82.
  27. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan H, Dzan V, Tarazi TM. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
  28. Aldrich HA, Roman MJ, De Simone G, Alderman MH, Devereux RB. Relation of age to left ventricular structure, function and systemic hemodynamics in normative and hypertensive employed adults. Am J Geriatr Cardiol 1992; 1:29-42.
  29. Kannel WB, Castelli WP, Mc Namara PM, Mc Kee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: the Framingham study. N Engl J Med 1972; 777-81.
  30. Munhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodeling in the subendocardial region of patients with hypertensive heart disease and hypertrophyc cardiomyopathy. Virchows arch 1997; 431:265-73.
  31. Beder SD, Gutgesell HP, Mullins GE, Mc Namara DG. Progression from hypertrophyc obstructive cardiomyopathy to congestive cardiomyopathy in a child. Am Heart J 1982; 104:155-62.
  32. Basso C, Thiene G, Corrado D, BujaG, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia. Hum Pathol 2000; 31:988-98.
  33. Davies MJ. The cardiomyopathies: A review of terminology pathology and pathogenesis. Histopathology 1984; 8:363-401.
  34. Roberts CHS, Roberts WC. Hypertrophyc cardiomyopathy as a cause of massive cardiomegaly (>1000g). Am J Cardiol 1989; 64:1209-11.
  35. Rose AG. Evaluation of pathological criteria for diagnosis of hypertrophyc cardiomyopathy. Histopathology 1984; 8:395-406.
  36. Goodwin JF, Hollman A, Deland WP, Teare D. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 1960: 22:403-14.
  37. Maron BJ, Roberts WC. Quantitative cell disorganization in the ventricular septum of patients with hypertrophyc cardiomyopathy. Circulation 1979; 59:689-706.
  38. D'Amanti G, Kahn HG, Butany HJ, Silver M. Altered distribution of desmin filaments in hypertrophyc cardiomyopathy: An inmunohistochemical study. Modern Pathol 1992; 5:165-8.
  39. Panza JA, Maron BJ. Simultaneons occurrence of mitral valve prolapse and systolic anterior motion in hypertrophyc cardiomyopathy. Am J Cardiol 1991; 67:404-10.
  40. Klnes HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophyc cardiomyopathy. Circulation 1992; 85:1651-60.
  41. Karam R, Lever H, Healy B. Hypertensive hypertrophyc cardiomyopathy or hypertrophyc cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 1989;13:580.
  42. Tanaka M, Fujiwara H, Onodera T. Quantitative análisis of myocardial fibrosis in normal hypertensive hearts and hipertrophic cardiomyopathy. Br Heart J 1986; 55:575-62.
Introducción
Hipertrofia Ventricular Izquierda: expresión anatómica de enfermedad del miocardio.
Miocardiopatía Hipertensiva
Miocardiopatía Hipertrófica
Diagnóstico diferencial entre Miocardiopatía Hipertensiva y Miocardiopatía Hipertrófica
Bibliografía

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit